EpiPen Controversy Fuels Concerns Over Generic Drug Approval Backlog
(By Sydney Lupkin for Kaiser Health News) Consumers and Congress members pushing for cheaper alternatives to the EpiPen and other
Read More
Gaps In Care Persist During Transition From Hospital To Home
(By Anna Gorman for Kaiser Health News) SAN DIEGO — Alton Rodgers had just come in from gardening when he suddenly
Read MoreSpike in a food-borne illness in Texas baffles health officials
(By Associated Press) DALLAS — Health officials are trying to determine why there’s been a dramatic increase in the number
Read MoreHidden network of kratom devotees tries to keep the supplement safe — and legal
(By Eric Boodman for STAT) When money is scarce, Margo Burton and her husband will go without cigarettes. Sometimes her
Read MoreFDA bans antibacterial soaps containing triclosan
(By Sheila Kaplan for STAT) WASHINGTON — In a major victory for environmentalists and public health advocates, the US Food
Read MoreAnyone see the rebates? Lawmakers accuse Mylan of underpaying Medicaid for EpiPen
(By Ed Silverman for STAT) Did Mylan Pharmaceuticals misclassify EpiPen to avoid paying higher Medicaid rebates? Continue reading article here…..
Read MoreHurdles abound in race to bring customized cancer treatments to masses
(By Meghana Keshavan for STAT) The idea is tantalizing: Reengineer a patient’s own immune cells to attack the cancer that’s
Read MoreAttending To The ‘Human Element’ Is Key To Keeping Patients Healthy
(By Shefali Luthra for Kaiser Health News) Racial minorities and lower-income people typically fare far worse when it comes to
Read MoreSimple Choice Plans’ To Debut In 2017 Marketplace Enrollment
(By Michelle Andrews for Kaiser Health News) Despite much hand-wringing about health insurers exiting the marketplaces where people buy individual coverage, in
Read MoreAn Even Deadlier Opioid, Carfentanil, Is Hitting The Streets
(By Jennifer Ludden for NPR) A powerful drug that’s normally used to tranquilize elephants is being blamed for a record
Read More